Manufacturing of Human Umbilical Cord Mesenchymal Stromal Cells on Microcarriers in a Dynamic System for Clinical Use

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Petry, Florian ^a,b   Smith, J Robert ^a   Leber, Jasmin ^b   Salzig, Denise ^b   Czermak, Peter ^b,c,d,e   Weiss, Mark L ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b TECHNISCHE HOCHSCHULE MITTELHESSEN   (Germany)

^c Kansas State University   (United States)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOREACTOR; CELL EXPANSION; CELL GROWTH; CELL ISOLATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INOCULATION; MALE; MESENCHYMAL STROMA CELL; MICROCARRIER CULTURE; PRIORITY JOURNAL; QUALITY CONTROL; UMBILICAL CORD;

EID: 84959108411     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/4834616     Document Type: Article

References (49)

1. C. L. Elseberg, J. Leber, D. Salzig et al., "Microcarrier-based expansion process for hMSCs with high vitality and undifferentiated characteristics," International Journal of Artificial Organs, vol. 35, no. 2, pp. 93-107, 2012.
2. D. Schop, F. W. Janssen, L. D. S. van Rijn et al., "Growth, metabolism, and growth inhibitors of mesenchymal stem cells," Tissue Engineering. Part A, vol. 15, no. 8, pp. 1877-1886, 2009.
3. D. J. Prockop, "Marrow stromal cells as stem cells for non-hematopoietic tissues," Science, vol. 276, no. 5309, pp. 71-74, 1997.
4. A. I. Caplan and S. P. Bruder, "Mesenchymal stem cells: building blocks for molecular medicine in the 21st century," Trends in Molecular Medicine, vol. 7, no. 6, pp. 259-264, 2001.
5. W. Wagner, F. Wein, A. Seckinger et al., "Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood," Experimental Hematology, vol. 33, no. 11, pp. 1402-1416, 2005.
6. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., "Multilineage potential of adult human mesenchymal stem cells," Science, vol. 284, no. 5411, pp. 143-147, 1999.
7. G. Kögler, S. Sensken, J. A. Airey et al., "A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential," Journal of Experimental Medicine, vol. 200, no. 2, pp. 123-135, 2004.
8. M. L. Weiss and D. L. Troyer, "Stem cells in the umbilical cord," Stem Cell Reviews, vol. 2, no. 2, pp. 155-162, 2006.
9. J. P. McGuirk, J. R. Smith, C. L. Divine, M. Zuniga, and M. L. Weiss, "Wharton's Jelly-derived mesenchymal stromal cells as a promising cellular therapeutic strategy for the management of graft-versus-host disease," Pharmaceuticals, vol. 8, no. 2, pp. 196-220, 2015.
10. T. Deuse, M. Stubbendorff, K. Tang-Quan et al., "Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells," Cell Transplantation, vol. 20, no. 5, pp. 655-667, 2011.
11. K. H. Yoo, I. K. Jang, M. W. Lee et al., "Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues," Cellular Immunology, vol. 259, no. 2, pp. 150-156, 2009.
12. M. Najar, G. Raicevic, H. I. Boufker et al., "Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor," Tissue Engineering Part A, vol. 16, no. 11, pp. 3537-3546, 2010.
13. S. J. Prasanna, D. Gopalakrishnan, S. R. Shankar, and A. B. Vasandan, "Pro-inflammatory cytokines, IFNγ and TNFα, influence immune properties of human bone marrow and wharton jelly mesenchymal stem cells differentially," PLoS ONE, vol. 5, no. 2, article e9016, 2010.
14. M. L. Weiss, C. Anderson, S. Medicetty et al., "Immune properties of human umbilical cord Wharton's jelly-derived cells," STEM CELLS, vol. 26, no. 11, pp. 2865-2874, 2008.
15. D. van Poll, B. Parekkadan, I. H. Borel Rinkes, A. W. Tilles, and M. L. Yarmush, "Mesenchymal stem cell therapy for protection and repair of injured vital organs," Cellular and Molecular Bioengineering, vol. 1, no. 1, pp. 42-50, 2008.
16. L. Wang, I. Tran, K. Seshareddy, M. L. Weiss, and M. S. Detamore, "A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering," Tissue Engineering Part A, vol. 15, no. 8, pp. 2259-2266, 2009.
17. J. R. Smith, K. Pfeiffer, F. Petry, N. Powell, J. Delzeit, and M. L. Weiss, "Standardizing umbilical cord mesenchymal stromal cells for translation to clinical use: selection of GMP-compliant medium and a simplified isolation method," Stem Cells International, In press.
18. M. Dominici, K. Le Blanc, I. Mueller et al., "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement," Cytotherapy, vol. 8, no. 4, pp. 315-317, 2006.
19. K. E. Mitchell, M. L. Weiss, B. M. Mitchell et al., "Matrix cells from Wharton's jelly form neurons and glia," STEM CELLS, vol. 21, no. 1, pp. 50-60, 2003.
20. L. B. Lester, Stem Cells in Endocrinology, Humana Press, 2007, https://books.google.com/books?id=WExKOQe3QWAC.
21. M. L. Weiss, S. Medicetty, A. R. Bledsoe et al., "Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease," Stem Cells, vol. 24, no. 3, pp. 781-792, 2006.
22. R. Sarugaser, D. Lickorish, D. Baksh, M. M. Hosseini, and J. E. Davies, "Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors," Stem Cells, vol. 23, no. 2, pp. 220-229, 2005.
23. K. C. Chao, K. F. Chao, Y. S. Fu, and S. H. Liu, "Islet-like clusters derived from mesenchymal stem cells in Wharton's jelly of the human umbilical cord for transplantation to control type 1 diabetes," PLoS ONE, vol. 3, no. 1, Article ID e1451, 2008.
24. Y.-C. Lin, T.-L. Ko, Y.-H. Shih et al., "Human umbilical mesenchymal stem cells promote recovery after ischemic stroke," Stroke, vol. 42, no. 7, pp. 2045-2053, 2011.
25. H.-S. Kim, T.-H. Shin, B.-C. Lee et al., "Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2," Gastroenterology, vol. 145, no. 6, pp. 1392-1403, 2013.
26. H.-S. Wang, S.-C. Hung, S.-T. Peng et al., "Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord," STEM CELLS, vol. 22, no. 7, pp. 1330-1337, 2004.
27. Y.-S. Fu, Y.-C. Cheng, M.-Y. A. Lin et al., "Conversion of human umbilical cord mesenchymal stem cells in Wharton's Jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism," Stem Cells, vol. 24, no. 1, pp. 115-124, 2006.
28. Y.-S. Fu, Y.-T. Shih, Y.-C. Cheng, and M.-Y. Min, "Transformation of human umbilical mesenchymal cells into neurons in vitro," Journal of Biomedical Science, vol. 11, no. 5, pp. 652-660, 2004.
29. Y. López, B. Lutjemeier, K. Seshareddy et al., "Wharton's jelly or bone marrow mesenchymal stromal cells improve cardiac function following myocardial infarction for more than 32 weeks in a rat model: a preliminary report," Current Stem Cell Research and Therapy, vol. 8, no. 1, pp. 46-59, 2013.
30. M. E. Bernardo, L. M. Ball, A. M. Cometa et al., "Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation," Bone Marrow Transplantation, vol. 46, no. 2, pp. 200-207, 2011.
31. K. Le Blanc, F. Frassoni, L. Ball et al., "Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study," The Lancet, vol. 371, no. 9624, pp. 1579-1586, 2008.
32. L. M. Ball, M. E. Bernardo, H. Roelofs et al., "Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease," British Journal of Haematology, vol. 163, no. 4, pp. 501-509, 2013.
33. R. Jitschin, D. Mougiakakos, L. von Bahr et al., "Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantation," Stem Cells, vol. 31, no. 8, pp. 1715-1725, 2013.
34. A. K.-L. Chen, Y. K. Chew, H. Y. Tan, S. Reuveny, and S. K. W. Oh, "Increasing efficiency of human mesenchymal stromal cell culture by optimization of microcarrier concentration and design of medium feed," Cytotherapy, vol. 17, no. 2, pp. 163-173, 2015.
35. F. Dos Santos, A. Campbell, A. Fernandes-Platzgummer et al., "A xenogeneic-free bioreactor system for the clinical-scale expansion of human mesenchymal stem/stromal cells," Biotechnology and Bioengineering, vol. 111, no. 6, pp. 1116-1127, 2014.
36. K. Cierpka, C. L. Elseberg, K. Niss, M. Kassem, D. Salzig, and P. Czermak, "hMSC production in disposable bioreactors with regards to GMP and PAT," Chemie Ingenieur Technik, vol. 85, no. 1-2, pp. 67-75, 2013.
37. J. Hupfeld, I. H. Gorr, C. Schwald et al., "Modulation of mesenchymal stromal cell characteristics by microcarrier culture in bioreactors," Biotechnology and Bioengineering, vol. 111, no. 11, pp. 2290-2302, 2014.
38. D. Baksh, R. Yao, and R. S. Tuan, "Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow," Stem Cells, vol. 25, no. 6, pp. 1384-1392, 2007.
39. I. Majore, P. Moretti, F. Stahl, R. Hass, and C. Kasper, "Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord," Stem Cell Reviews and Reports, vol. 7, no. 1, pp. 17-31, 2011.
40. S. S. Ozturk and B. O. Palsson, "Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 2. Effects of serum concentration, dissolved oxygen concentration, and medium pH in a batch reactor," Biotechnology Progress, vol. 7, no. 6, pp. 481-494, 1991.
41. J. Ljunggren and L. Häggström, "Catabolic control of hybridoma cells by glucose and glutamine limited fed batch cultures," Biotechnology and Bioengineering, vol. 44, no. 7, pp. 808-818, 1994.
42. M. W. Glacken, "Catabolic control of mammalian cell culture," Bio/Technology, vol. 6, no. 9, pp. 1041-1050, 1988.
43. G. L. Tritsch and G. E. Moore, "Spontaneous decomposition of glutamine in cell culture media," Experimental Cell Research, vol. 28, no. 2, pp. 360-364, 1962.
44. M.-S. Lao and D. Toth, "Effects of ammonium and lactate on growth and metabolism of a recombinant Chinese hamster ovary cell culture," Biotechnology Progress, vol. 13, no. 5, pp. 688-691, 1997.
45. T. K. Goh, Z. Zhang, A. K. Chen et al., "Microcarrier culture for efficient expansion and osteogenic differentiation of human fetal mesenchymal stem cells," BioResearch Open Access, vol. 2, no. 2, pp. 84-97, 2013.
46. P.-C. Tseng, T.-H. Young, T.-M. Wang, H.-W. Peng, S.-M. Hou, and M.-L. Yen, "Spontaneous osteogenesis of MSCs cultured on 3D microcarriers through alteration of cytoskeletal tension," Biomaterials, vol. 33, no. 2, pp. 556-564, 2012.
47. H. Chmiel, Bioprozesstechnik, Spektrum Akademischer, Heidelberg, Germany, 3rd edition, 2011.
48. W. S. Hu, J. Meier, and D. I. C. Wang, "A mechanistic analysis of the inoculum requirement for the cultivation of mammalian cells on microcarriers," Biotechnology and Bioengineering, vol. 27, no. 5, pp. 585-595, 1985.
49. C. Götherström, A. West, J. Liden, M. Uzunel, R. Lahesmaa, and K. Le Blanc, "Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells," Haematologica, vol. 90, no. 8, pp. 1017-1026, 2005.